Atlas Trials

Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic

Clinical trial NCT05293431 · UNKNOWN

Trial details

NCT number
NCT05293431
Sponsor
Institut Guttmann
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Transcranial Direct Current StimulationMental Health IssuePublic HealthResilience, PsychologicalCOVID-19
Start date
2022-09-01
Primary completion
2023-07-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.